Skip to content

Drug interactions

Rucaparib + Tolvaptan

Severity: Moderate

Rucaparib and Tolvaptan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib is a weak-to-moderate inhibitor of CYP3A4 and may raise tolvaptan concentrations, which is a sensitive CYP3A4 substrate. Increased exposure can cause excessive aquaresis, thirst and too rapid sodium correction.

What this interaction means in plain words

Rucaparib and Tolvaptan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Rucaparib belongs to Oncology; Tolvaptan belongs to Endocrine.

Evidence level: Low

Why it happens

Inhibition of CYP3A4-mediated tolvaptan metabolism by rucaparib.

What to do

Monitor serum sodium and volume status and consider lowering the tolvaptan dose if adverse effects appear.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rucaparib and Tolvaptan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rucaparib with Tolvaptan?

MediHelp rates the interaction as moderate. Rucaparib and Tolvaptan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rucaparib is a weak-to-moderate inhibitor of CYP3A4 and may raise tolvaptan concentrations, which is a sensitive CYP3A4 substrate. Increased exposure can cause excessive aquaresis, thirst and too rapid sodium correction.

How serious is the interaction between Rucaparib and Tolvaptan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum sodium and volume status and consider lowering the tolvaptan dose if adverse effects appear.

What other medicines interact with Tolvaptan?

MediHelp also lists interactions of Tolvaptan with, for example, Atazanavir, Ceritinib, Cobicistat. The full list is on the Tolvaptan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in